Want to join the conversation?
$ABT 2Q15 PR: Received European approval for Absorb GT1; completed submissions for regulatory approval of Absorb in Japan & US; submitted for US regulatory approval of FreeStyle Libre Pro Flash Glucose Monitoring System for professional use; received US FDA clearance for its i-STAT handheld system.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.